A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research [0.03%]
用于迷幻蘑菇试验的研究材料的现场回顾和分析：对二十年研究的评估
David B Yaden,Marianna Graziosi,Alexa M Owen et al.
David B Yaden et al.
Introduction: Serotonergic psychedelics, serotonin 2A receptor agonists such as psilocybin that can result in substantially altered states of consciousness, are used in recreational and research settings. The safety of ps...
Rebecca Ehrenkranz,Manish Agrawal,Sandeep M Nayak et al.
Rebecca Ehrenkranz et al.
Research has demonstrated both risks and benefits to using psychedelics as a therapeutic intervention for a variety of mental health conditions. In recent years, the public discourse around psychedelic treatments has been largely positive a...
Psychedelic Therapist Sexual Misconduct and Other Adverse Experiences Among a Sample of Naturalistic Psychedelic Users [0.03%]
一种针对自然主义迷幻药使用者样本的研究：心理治疗师的不当行为及其他不良经历
Daniel J Kruger,Jacob S Aday,Christopher W Fields et al.
Daniel J Kruger et al.
Introduction: Psychedelic substances have been used for centuries in various cultural and religious contexts, and more recently, in clinical research and therapy. There is a surge of interest in psychedelics, and psychede...
A Systematic Review of Study Design and Placebo Controls in Psychedelic Research [0.03%]
psychedelics研究中的研究设计和安慰剂控制的系统回顾
Alexander Wen,Nikhita Singhal,Brett D M Jones et al.
Alexander Wen et al.
Introduction: Effective blinding is especially challenging in randomized controlled trials (RCTs) involving psychedelics due to the inherent alterations in consciousness that these compounds induce. In this systematic rev...
Preadministration of Lorazepam Reduces Efficacy and Longevity of Antidepressant-Like Effect from a Psychedelic [0.03%]
劳拉西泮的预先给药会降低类似抗抑郁效果的效力和持续时间
Meghan Hibicke,Gerald Billac,Charles D Nichols
Meghan Hibicke
Introduction: Psychedelics such as psilocybin have been shown to have persistent antidepressant effects, but with considerable individual variability in optimal dosing. Intravenous (IV) dosing is rapid onset and quickly t...
American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A 7-Year Follow-Up Survey [0.03%]
美国精神病学家对于经典幻觉素及其潜在治疗应用的态度：一项为期七年的随访调查研究
Brian S Barnett,Miranda Arakelian,David Beebe et al.
Brian S Barnett et al.
Background: Psilocybin, a classic hallucinogen, may eventually be approved by the United States Food and Drug Administration for treatment-resistant depression. However, we are aware of only one published national survey ...
The Mystical Experience Questionnaire 4-Item and Challenging Experience Questionnaire 7-Item [0.03%]
神秘体验问卷4条目和挑战性体验问卷7条目
Justin C Strickland,Albert Garcia-Romeu,Matthew W Johnson
Justin C Strickland
Background: The Mystical Experience Questionnaire (MEQ-30) and Challenging Effects Questionnaire (CEQ) are two of the most widely used, validated instruments to probe subjective effects of psychedelic drugs. However, thes...
Psychedelic Research as a Career Path: A Roundtable Discussion with Early Career Researchers in the Field [0.03%]
职业路径探讨：一场与迷幻研究领域年轻科研人员的圆桌讨论会
Jacob S Aday,Natasha L Mason,Bo Jarrett Wood et al.
Jacob S Aday et al.
Getting in Touch with Touch: The Importance of Studying Touch in MDMA-Assisted Therapy and the Development of a New Self-Report Measure [0.03%]
触摸的接触：在MDMA辅助治疗中研究触摸的重要性及新自我报告措施的开发
Jason Luoma,Luke R Allen,Veronika Gold et al.
Jason Luoma et al.
Background: MDMA-assisted therapy (MDMA-AT) is an emerging treatment modality, with recent phase 3 trials indicating its potential for regulatory approval. Central to this therapy is the role of touch, yet its empirical e...
Nurses' Perceptions of Psychedelics to Address Mental Health Problems in the United States [0.03%]
美国护士对于使用迷幻药物解决精神健康问题的看法
Carolyn M Porta,Madison E Weirick,Anna Graefe et al.
Carolyn M Porta et al.
Objective: To explore nurses' knowledge, attitudes, and perceived social norms about psychedelic use to address mental health conditions. Methods: ...